A. Speakers (, Switzerland)

Author Of 31 Presentations

 Conference Calendar
Adjuvant treatment early HER+ in breast cancer Educational session

Q&A and live discussion (ID 32)

Lecture Time
17:35 - 17:45
Speakers
Session Name
Adjuvant treatment early HER+ in breast cancer
Room
Channel 1
Date
Sat, 08.05.2021
Time
16:30 - 17:45
Novartis Oncology - What makes the difference in treating HR+, HER2– ABC? Industry Satellite Symposia

Discussion (ID 355)

Lecture Time
19:40 - 19:50
Speakers
Session Name
Novartis Oncology - What makes the difference in treating HR+, HER2– ABC?
Room
Channel 1
Date
Thu, 06.05.2021
Time
19:00 - 20:00
Impact of ethnicity-based differences in breast cancer Educational session

Q&A and live discussion (ID 294)

Lecture Time
16:50 - 17:00
Speakers
Session Name
Impact of ethnicity-based differences in breast cancer
Room
Channel 2
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Proffered Paper session 1 Proffered paper

Q&A and live discussion (ID 246)

Lecture Time
15:23 - 15:30
Speakers
Session Name
Proffered Paper session 1
Room
Channel 2
Date
Fri, 07.05.2021
Time
14:15 - 15:30
Optimizing the management of premenopausal women with early breast cancer Educational session

Q&A and live discussion (ID 7)

Lecture Time
16:05 - 16:15
Speakers
Session Name
Optimizing the management of premenopausal women with early breast cancer
Room
Channel 1
Date
Sat, 08.05.2021
Time
15:00 - 16:15
CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes Industry Satellite Symposia

Summary, final thoughts and live Q&A (ID 339)

Lecture Time
19:45 - 19:55
Speakers
Session Name
CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes
Room
Channel 1
Date
Wed, 05.05.2021
Time
19:00 - 20:00
Mini Oral session 2 Mini oral

Q&A and live discussion (ID 270)

Lecture Time
13:13 - 13:26
Speakers
Session Name
Mini Oral session 2
Room
Channel 2
Date
Sat, 08.05.2021
Time
12:45 - 14:00
Early drug development in breast cancer Educational session

Q&A and live discussion (ID 38)

Lecture Time
17:35 - 17:45
Speakers
Session Name
Early drug development in breast cancer
Room
Channel 3
Date
Sat, 08.05.2021
Time
16:30 - 17:45
Novartis Oncology - What makes the difference in treating HR+, HER2– ABC? Industry Satellite Symposia

Live Q&A session (ID 356)

Lecture Time
19:50 - 20:00
Speakers
Session Name
Novartis Oncology - What makes the difference in treating HR+, HER2– ABC?
Room
Channel 1
Date
Thu, 06.05.2021
Time
19:00 - 20:00
Neoadjuvant/adjuvant treatment of HER2+ Multidisciplinary tumour board

Q&A and live discussion (ID 300)

Lecture Time
16:50 - 17:00
Speakers
Session Name
Neoadjuvant/adjuvant treatment of HER2+
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Proffered Paper session 2 Proffered paper

Q&A and live discussion (ID 251)

Lecture Time
17:01 - 17:08
Speakers
Session Name
Proffered Paper session 2
Room
Channel 2
Date
Sat, 08.05.2021
Time
16:30 - 17:45
Brain mets management in HER2+ and triple negative breast cancer Educational session

Q&A and live discussion (ID 15)

Lecture Time
16:05 - 16:15
Speakers
Session Name
Brain mets management in HER2+ and triple negative breast cancer
Room
Channel 2
Date
Sat, 08.05.2021
Time
15:00 - 16:15
Daiichi-Sankyo/AstraZeneca - ADCs for ABC: Antibody-drug conjugates for advanced/metastatic breast cancer Industry Satellite Symposia

Panel discussion and Q&A (ID 342)

Lecture Time
16:35 - 16:55
Speakers
Session Name
Daiichi-Sankyo/AstraZeneca - ADCs for ABC: Antibody-drug conjugates for advanced/metastatic breast cancer
Room
Channel 1
Date
Thu, 06.05.2021
Time
16:00 - 17:00
Mini Oral session 2 Mini oral

Q&A and live discussion (ID 274)

Lecture Time
13:46 - 14:00
Speakers
Session Name
Mini Oral session 2
Room
Channel 2
Date
Sat, 08.05.2021
Time
12:45 - 14:00
Optimal sequence in metastatic HER2+ breast cancer Educational session

Q&A and live discussion (ID 231)

Lecture Time
13:50 - 14:00
Speakers
Session Name
Optimal sequence in metastatic HER2+ breast cancer
Room
Channel 1
Date
Fri, 07.05.2021
Time
12:45 - 14:00
MSD - Advanced TNBC: Emerging landscape and treatment options Industry Satellite Symposia

Patient case study (ID 366)

Lecture Time
18:15 - 18:25
Speakers
Session Name
MSD - Advanced TNBC: Emerging landscape and treatment options
Room
Channel 2
Date
Wed, 05.05.2021
Time
17:30 - 18:30
Optimal sequence in metastatic ER+ breast cancer Educational session

Q&A and live discussion (ID 306)

Lecture Time
16:50 - 17:00
Speakers
Session Name
Optimal sequence in metastatic ER+ breast cancer
Room
Channel 3
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Proffered Paper session 2 Proffered paper

Q&A and live discussion (ID 255)

Lecture Time
17:38 - 17:45
Speakers
Session Name
Proffered Paper session 2
Room
Channel 2
Date
Sat, 08.05.2021
Time
16:30 - 17:45
Immunotherapy in metastatic breast cancer (mBC) Educational session

Q&A and live discussion (ID 20)

Lecture Time
13:50 - 14:00
Speakers
Session Name
Immunotherapy in metastatic breast cancer (mBC)
Room
Channel 1
Date
Sat, 08.05.2021
Time
12:45 - 14:00
Pfizer Oncology - Navigating a new clinical reality in advanced breast cancer: Treatment considerations in the real world Industry Satellite Symposia

Q&A discussion (ID 347)

Lecture Time
18:15 - 18:30
Speakers
Session Name
Pfizer Oncology - Navigating a new clinical reality in advanced breast cancer: Treatment considerations in the real world
Room
Channel 1
Date
Thu, 06.05.2021
Time
17:30 - 18:30
Precision medicine in breast cancer Educational session

Q&A and live discussion (ID 280)

Lecture Time
13:50 - 14:00
Speakers
Session Name
Precision medicine in breast cancer
Room
Channel 3
Date
Fri, 07.05.2021
Time
12:45 - 14:00
Best abstracts Proffered paper

Q&A and live discussion (ID 237)

Lecture Time
18:07 - 18:30
Speakers
Session Name
Best abstracts
Room
Channel 1
Date
Fri, 07.05.2021
Time
17:15 - 18:30
ESMO Breast Cancer 2020 Award lecture Keynote

Live welcome (ID 384)

Lecture Time
12:00 - 12:01
Speakers
Session Name
ESMO Breast Cancer 2020 Award lecture
Room
Channel 1
Date
Sat, 08.05.2021
Time
12:00 - 12:30
YO Boxing session Young oncologist session

Q&A and live discussion (ID 312)

Lecture Time
15:20 - 15:30
Speakers
Session Name
YO Boxing session
Room
Channel 3
Date
Fri, 07.05.2021
Time
14:15 - 15:30
Mini Oral session 1 Mini oral

Q&A and live discussion (ID 260)

Lecture Time
13:10 - 13:25
Speakers
Session Name
Mini Oral session 1
Room
Channel 2
Date
Fri, 07.05.2021
Time
12:45 - 13:45
Testing recommendation in breast cancer Educational session

Q&A and live discussion (ID 26)

Lecture Time
16:05 - 16:15
Speakers
Session Name
Testing recommendation in breast cancer
Room
Channel 3
Date
Sat, 08.05.2021
Time
15:00 - 16:15
Novartis Oncology - What makes the difference in treating HR+, HER2– ABC? Industry Satellite Symposia

Discussion (ID 352)

Lecture Time
19:20 - 19:30
Speakers
Session Name
Novartis Oncology - What makes the difference in treating HR+, HER2– ABC?
Room
Channel 1
Date
Thu, 06.05.2021
Time
19:00 - 20:00
Neoadjuvant/adjuvant treatment in triple negative breast cancer (TNBC) Educational session

Q&A and live discussion (ID 288)

Lecture Time
15:20 - 15:30
Speakers
Session Name
Neoadjuvant/adjuvant treatment in triple negative breast cancer (TNBC)
Room
Channel 1
Date
Fri, 07.05.2021
Time
14:15 - 15:30
Proffered Paper session 1 Proffered paper

Q&A and live discussion (ID 242)

Lecture Time
14:46 - 14:53
Speakers
Session Name
Proffered Paper session 1
Room
Channel 2
Date
Fri, 07.05.2021
Time
14:15 - 15:30
YOC Forum - The future of academic research in oncology: Is there a role for young oncologists? Young oncologist session

Q&A and live discussion (ID 318)

Lecture Time
13:50 - 14:00
Speakers
Session Name
YOC Forum - The future of academic research in oncology: Is there a role for young oncologists?
Room
Channel 3
Date
Sat, 08.05.2021
Time
12:45 - 14:00
Mini Oral session 1 Mini oral

Q&A and live discussion (ID 264)

Lecture Time
13:38 - 13:45
Speakers
Session Name
Mini Oral session 1
Room
Channel 2
Date
Fri, 07.05.2021
Time
12:45 - 13:45

Presenter Of 31 Presentations

 Conference Calendar
Mini Oral session 1 Mini oral

Q&A and live discussion (ID 260)

Lecture Time
13:10 - 13:25
Speakers
Session Name
Mini Oral session 1
Room
Channel 2
Date
Fri, 07.05.2021
Time
12:45 - 13:45
Testing recommendation in breast cancer Educational session

Q&A and live discussion (ID 26)

Lecture Time
16:05 - 16:15
Speakers
Session Name
Testing recommendation in breast cancer
Room
Channel 3
Date
Sat, 08.05.2021
Time
15:00 - 16:15
Novartis Oncology - What makes the difference in treating HR+, HER2– ABC? Industry Satellite Symposia

Discussion (ID 352)

Lecture Time
19:20 - 19:30
Speakers
Session Name
Novartis Oncology - What makes the difference in treating HR+, HER2– ABC?
Room
Channel 1
Date
Thu, 06.05.2021
Time
19:00 - 20:00
Neoadjuvant/adjuvant treatment in triple negative breast cancer (TNBC) Educational session

Q&A and live discussion (ID 288)

Lecture Time
15:20 - 15:30
Speakers
Session Name
Neoadjuvant/adjuvant treatment in triple negative breast cancer (TNBC)
Room
Channel 1
Date
Fri, 07.05.2021
Time
14:15 - 15:30
Proffered Paper session 1 Proffered paper

Q&A and live discussion (ID 242)

Lecture Time
14:46 - 14:53
Speakers
Session Name
Proffered Paper session 1
Room
Channel 2
Date
Fri, 07.05.2021
Time
14:15 - 15:30
YOC Forum - The future of academic research in oncology: Is there a role for young oncologists? Young oncologist session

Q&A and live discussion (ID 318)

Lecture Time
13:50 - 14:00
Speakers
Session Name
YOC Forum - The future of academic research in oncology: Is there a role for young oncologists?
Room
Channel 3
Date
Sat, 08.05.2021
Time
12:45 - 14:00
Mini Oral session 1 Mini oral

Q&A and live discussion (ID 264)

Lecture Time
13:38 - 13:45
Speakers
Session Name
Mini Oral session 1
Room
Channel 2
Date
Fri, 07.05.2021
Time
12:45 - 13:45
Adjuvant treatment early HER+ in breast cancer Educational session

Q&A and live discussion (ID 32)

Lecture Time
17:35 - 17:45
Speakers
Session Name
Adjuvant treatment early HER+ in breast cancer
Room
Channel 1
Date
Sat, 08.05.2021
Time
16:30 - 17:45
Novartis Oncology - What makes the difference in treating HR+, HER2– ABC? Industry Satellite Symposia

Discussion (ID 355)

Lecture Time
19:40 - 19:50
Speakers
Session Name
Novartis Oncology - What makes the difference in treating HR+, HER2– ABC?
Room
Channel 1
Date
Thu, 06.05.2021
Time
19:00 - 20:00
Impact of ethnicity-based differences in breast cancer Educational session

Q&A and live discussion (ID 294)

Lecture Time
16:50 - 17:00
Speakers
Session Name
Impact of ethnicity-based differences in breast cancer
Room
Channel 2
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Proffered Paper session 1 Proffered paper

Q&A and live discussion (ID 246)

Lecture Time
15:23 - 15:30
Speakers
Session Name
Proffered Paper session 1
Room
Channel 2
Date
Fri, 07.05.2021
Time
14:15 - 15:30
Optimizing the management of premenopausal women with early breast cancer Educational session

Q&A and live discussion (ID 7)

Lecture Time
16:05 - 16:15
Speakers
Session Name
Optimizing the management of premenopausal women with early breast cancer
Room
Channel 1
Date
Sat, 08.05.2021
Time
15:00 - 16:15
CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes Industry Satellite Symposia

Summary, final thoughts and live Q&A (ID 339)

Lecture Time
19:45 - 19:55
Speakers
Session Name
CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes
Room
Channel 1
Date
Wed, 05.05.2021
Time
19:00 - 20:00
Mini Oral session 2 Mini oral

Q&A and live discussion (ID 270)

Lecture Time
13:13 - 13:26
Speakers
Session Name
Mini Oral session 2
Room
Channel 2
Date
Sat, 08.05.2021
Time
12:45 - 14:00
Early drug development in breast cancer Educational session

Q&A and live discussion (ID 38)

Lecture Time
17:35 - 17:45
Speakers
Session Name
Early drug development in breast cancer
Room
Channel 3
Date
Sat, 08.05.2021
Time
16:30 - 17:45
Novartis Oncology - What makes the difference in treating HR+, HER2– ABC? Industry Satellite Symposia

Live Q&A session (ID 356)

Lecture Time
19:50 - 20:00
Speakers
Session Name
Novartis Oncology - What makes the difference in treating HR+, HER2– ABC?
Room
Channel 1
Date
Thu, 06.05.2021
Time
19:00 - 20:00
Neoadjuvant/adjuvant treatment of HER2+ Multidisciplinary tumour board

Q&A and live discussion (ID 300)

Lecture Time
16:50 - 17:00
Speakers
Session Name
Neoadjuvant/adjuvant treatment of HER2+
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Proffered Paper session 2 Proffered paper

Q&A and live discussion (ID 251)

Lecture Time
17:01 - 17:08
Speakers
Session Name
Proffered Paper session 2
Room
Channel 2
Date
Sat, 08.05.2021
Time
16:30 - 17:45
Brain mets management in HER2+ and triple negative breast cancer Educational session

Q&A and live discussion (ID 15)

Lecture Time
16:05 - 16:15
Speakers
Session Name
Brain mets management in HER2+ and triple negative breast cancer
Room
Channel 2
Date
Sat, 08.05.2021
Time
15:00 - 16:15
Daiichi-Sankyo/AstraZeneca - ADCs for ABC: Antibody-drug conjugates for advanced/metastatic breast cancer Industry Satellite Symposia

Panel discussion and Q&A (ID 342)

Lecture Time
16:35 - 16:55
Speakers
Session Name
Daiichi-Sankyo/AstraZeneca - ADCs for ABC: Antibody-drug conjugates for advanced/metastatic breast cancer
Room
Channel 1
Date
Thu, 06.05.2021
Time
16:00 - 17:00
Mini Oral session 2 Mini oral

Q&A and live discussion (ID 274)

Lecture Time
13:46 - 14:00
Speakers
Session Name
Mini Oral session 2
Room
Channel 2
Date
Sat, 08.05.2021
Time
12:45 - 14:00
Optimal sequence in metastatic HER2+ breast cancer Educational session

Q&A and live discussion (ID 231)

Lecture Time
13:50 - 14:00
Speakers
Session Name
Optimal sequence in metastatic HER2+ breast cancer
Room
Channel 1
Date
Fri, 07.05.2021
Time
12:45 - 14:00
MSD - Advanced TNBC: Emerging landscape and treatment options Industry Satellite Symposia

Patient case study (ID 366)

Lecture Time
18:15 - 18:25
Speakers
Session Name
MSD - Advanced TNBC: Emerging landscape and treatment options
Room
Channel 2
Date
Wed, 05.05.2021
Time
17:30 - 18:30
Optimal sequence in metastatic ER+ breast cancer Educational session

Q&A and live discussion (ID 306)

Lecture Time
16:50 - 17:00
Speakers
Session Name
Optimal sequence in metastatic ER+ breast cancer
Room
Channel 3
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Proffered Paper session 2 Proffered paper

Q&A and live discussion (ID 255)

Lecture Time
17:38 - 17:45
Speakers
Session Name
Proffered Paper session 2
Room
Channel 2
Date
Sat, 08.05.2021
Time
16:30 - 17:45
Immunotherapy in metastatic breast cancer (mBC) Educational session

Q&A and live discussion (ID 20)

Lecture Time
13:50 - 14:00
Speakers
Session Name
Immunotherapy in metastatic breast cancer (mBC)
Room
Channel 1
Date
Sat, 08.05.2021
Time
12:45 - 14:00
Pfizer Oncology - Navigating a new clinical reality in advanced breast cancer: Treatment considerations in the real world Industry Satellite Symposia

Q&A discussion (ID 347)

Lecture Time
18:15 - 18:30
Speakers
Session Name
Pfizer Oncology - Navigating a new clinical reality in advanced breast cancer: Treatment considerations in the real world
Room
Channel 1
Date
Thu, 06.05.2021
Time
17:30 - 18:30
Precision medicine in breast cancer Educational session

Q&A and live discussion (ID 280)

Lecture Time
13:50 - 14:00
Speakers
Session Name
Precision medicine in breast cancer
Room
Channel 3
Date
Fri, 07.05.2021
Time
12:45 - 14:00
Best abstracts Proffered paper

Q&A and live discussion (ID 237)

Lecture Time
18:07 - 18:30
Speakers
Session Name
Best abstracts
Room
Channel 1
Date
Fri, 07.05.2021
Time
17:15 - 18:30
ESMO Breast Cancer 2020 Award lecture Keynote

Live welcome (ID 384)

Lecture Time
12:00 - 12:01
Speakers
Session Name
ESMO Breast Cancer 2020 Award lecture
Room
Channel 1
Date
Sat, 08.05.2021
Time
12:00 - 12:30
YO Boxing session Young oncologist session

Q&A and live discussion (ID 312)

Lecture Time
15:20 - 15:30
Speakers
Session Name
YO Boxing session
Room
Channel 3
Date
Fri, 07.05.2021
Time
14:15 - 15:30